ASAH1 and melanoma: In line with this interesting effect, deletion of ASAH1 using CRISPR-Cas9 in A375 melanoma cells was found to disrupt ceramide metabolism and directed cells towards either apoptosis or senescence [59], suggesting that ASAH1 may potentially be a therapeutic target for both cancer and senescence.